Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

376
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
376
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

1.6K
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.6K
Lipid Absorption01:24

Lipid Absorption

3.9K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
3.9K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.9K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K
Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

114.0K
Overview
114.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SUCNR1 coordinates metabolic flux, mitochondrial function, and nutrient-dependent adaptation in hepatocytes.

Science advances·2026
Same author

Corrigendum to: ApoB100 remodeling and stiffened cholesteryl ester core raise LDL aggregation in familial hypercholesterolemia patients [Journal of Lipid Research 66/1 (2025) 100703].

Journal of lipid research·2026
Same author

Special issue: Lipid metabolic alterations in cancer: Pathogenic mechanisms, therapies and common pathophysiology with cardiovascular disease.

Seminars in cancer biology·2026
Same author

Polymeric immunoglobulin receptor deficiency attenuates experimental atherosclerosis.

Frontiers in immunology·2026
Same author

Altered small dense LDL profiles in long-standing controlled type 1 diabetes.

Frontiers in endocrinology·2026
Same author

The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptors.

Biochemical pharmacology·2026

Related Experiment Video

Updated: Apr 19, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

31.0K

Cholesterol efflux and reverse cholesterol transport.

Elda Favari1, Angelika Chroni, Uwe J F Tietge

  • 1Department of Pharmacy, University of Parma, Parco Area delle Scienze 27/A, 43124, Parma, Italy.

Handbook of Experimental Pharmacology
|December 20, 2014
PubMed
Summary

Reverse cholesterol transport (RCT) removes excess cholesterol from artery walls, reducing atherosclerosis. Measuring cholesterol efflux capacity (CEC) predicts cardiovascular disease risk better than high-density lipoprotein (HDL) levels alone.

More Related Videos

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay
08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

9.7K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

558

Related Experiment Videos

Last Updated: Apr 19, 2026

Cholesterol Efflux Assay
07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

31.0K
High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay
08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

9.7K
High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

558

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Atherosclerosis Research

Background:

  • Atherosclerotic plaque formation involves lipid metabolism and inflammation, leading to cholesterol and macrophage accumulation in arteries.
  • Reverse cholesterol transport (RCT) counteracts atheroma development by facilitating high-density lipoprotein (HDL)-mediated cholesterol removal.
  • RCT efficiency is inversely related to atherosclerotic cardiovascular diseases (CVD), suggesting it as a therapeutic target.

Purpose of the Study:

  • To investigate the role of HDL in RCT and its potential as a strategy for reducing atherosclerotic plaque burden.
  • To evaluate whether HDL function, specifically cholesterol efflux capacity (CEC), is a better predictor of CVD than plasma HDL levels.

Main Methods:

  • Review of in vivo studies examining the relationship between RCT efficiency and CVD.
  • Analysis of HDL's role in cholesterol efflux, lipoprotein remodeling, and hepatic lipid uptake.
  • Assessment of serum cholesterol efflux capacity (CEC) as a predictor of atherosclerosis.

Main Results:

  • RCT, mediated by HDL, promotes cholesterol removal from artery walls, counteracting atherosclerosis.
  • HDL's antiatherogenic functions may be independent of its plasma levels, challenging traditional associations.
  • Serum CEC is demonstrated to be a predictor of atherosclerosis extent in humans.

Conclusions:

  • Promoting RCT may offer a novel strategy to reduce cardiovascular events.
  • Assessing HDL function through CEC provides a more accurate prediction of CVD risk than HDL levels alone.
  • CEC evaluation is a valuable tool for predicting atherosclerosis extent.